149 related articles for article (PubMed ID: 1820660)
1. "Yellow nail syndrome" and rheumatoid arthritis.
Ichikawa Y; Shimizu H; Arimori S
Tokai J Exp Clin Med; 1991 Dec; 16(5-6):203-9. PubMed ID: 1820660
[TBL] [Abstract][Full Text] [Related]
2. Yellow nails under bucillamine therapy for rheumatoid arthritis: a report of two cases.
Yamamoto T; Yokozeki H
Rheumatol Int; 2007 Apr; 27(6):603-4. PubMed ID: 17103174
[No Abstract] [Full Text] [Related]
3. Membranous glomerulonephritis in patients with rheumatoid arthritis.
Yoshida A; Morozumi K; Takeda A; Koyama K; Oikawa T
Clin Ther; 1994; 16(6):1000-6. PubMed ID: 7697679
[TBL] [Abstract][Full Text] [Related]
4. Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome.
Baran R; Thomas L
J Drugs Dermatol; 2009 Mar; 8(3):276-8. PubMed ID: 19271377
[TBL] [Abstract][Full Text] [Related]
5. [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine].
Amasaki Y; Sagawa A; Atsumi T; Jodo S; Nakabayashi T; Watanabe I; Mukai M; Fujisaku A; Nakagawa S; Kobayashi H
Ryumachi; 1991 Oct; 31(5):528-34; discussion 531-3. PubMed ID: 1837388
[TBL] [Abstract][Full Text] [Related]
6. Yellow nail syndrome associated with penicillamine therapy.
Ilchyshyn A; Vickers CF
Acta Derm Venereol; 1983; 63(6):554-5. PubMed ID: 6198852
[TBL] [Abstract][Full Text] [Related]
7. [Bucillamine-associated membranous nephropathy in a patient with rheumatoid arthritis].
Kawano M; Nomura H; Iwainaka Y; Nakashima A; Koni I; Tofuku Y; Takeda R
Nihon Jinzo Gakkai Shi; 1990 Jul; 32(7):817-21. PubMed ID: 2273598
[TBL] [Abstract][Full Text] [Related]
8. [Yellow-nail syndrome from d-penicillamine].
Lubach D; Marghescu S
Hautarzt; 1979 Oct; 30(10):547-9. PubMed ID: 521278
[TBL] [Abstract][Full Text] [Related]
9. Yellow nail induced by bucillamine.
Ishizaki C; Sueki H; Kohsokabe S; Nishida H
Int J Dermatol; 1995 Jul; 34(7):493-4. PubMed ID: 7591416
[No Abstract] [Full Text] [Related]
10. Nail-changes induced by penicillamine.
Bjellerup M
Acta Derm Venereol; 1989; 69(4):339-41. PubMed ID: 2568058
[TBL] [Abstract][Full Text] [Related]
11. Yellow nail syndrome: not a genetic disorder? Eleven new cases and a review of the literature.
Hoque SR; Mansour S; Mortimer PS
Br J Dermatol; 2007 Jun; 156(6):1230-4. PubMed ID: 17459037
[TBL] [Abstract][Full Text] [Related]
12. Immunopharmacological evaluation of bucillamine in rheumatoid arthritis.
Matsuno H; Kitano T; Matsushita I; Tsuji H; Ochiai H
Drugs Exp Clin Res; 1993; 19(5):205-11. PubMed ID: 8174492
[TBL] [Abstract][Full Text] [Related]
13. [A case of rheumatoid arthritis with bucillamine-induced myasthenia gravis treated by immunoadsorption therapy].
Sawa N; Ubara Y; Hara S; Hideyuki K; Tagami T; Yokoyama K; Takemoto F; Yamada A; Mori T; Mikami A; Tachibana S; Nakase K
Ryumachi; 1999 Feb; 39(1):33-8. PubMed ID: 10332215
[TBL] [Abstract][Full Text] [Related]
14. [Clinicopathological study of nephropathy in patients with rheumatoid arthritis].
Yoshida A; Morozumi K; Suganuma T; Aoki J; Sugito K; Koyama K; Oikawa T; Fujinimi T; Matsumoto Y
Ryumachi; 1991 Feb; 31(1):14-21. PubMed ID: 1677490
[TBL] [Abstract][Full Text] [Related]
15. [A case of rheumatoid arthritis associated with agranulocytosis during bucillamine treatment].
Negishi M; Yamazaki J; Hosaka M; Iwabuchi H; Matsuda A; Kanemitsu H; Hiramatsu K; Kaga S; Hashimoto M; Kasama T
Ryumachi; 1994 Jun; 34(3):651-5. PubMed ID: 8052932
[TBL] [Abstract][Full Text] [Related]
16. Yellow nail syndrome.
Maldonado F; Ryu JH
Curr Opin Pulm Med; 2009 Jul; 15(4):371-5. PubMed ID: 19373089
[TBL] [Abstract][Full Text] [Related]
17. [Lung injury associated with bucillamine therapy].
Negishi M; Kaga S; Kasama T; Hashimoto M; Fukushima T; Yamagata N; Tabata M; Kobayashi K; Ide H; Takahashi T
Ryumachi; 1992 Apr; 32(2):135-9. PubMed ID: 1595005
[TBL] [Abstract][Full Text] [Related]
18. Yellow nail syndrome.
Elmariah SB; Ubriani RR; Kovich O
Dermatol Online J; 2008 Oct; 14(10):17. PubMed ID: 19061616
[TBL] [Abstract][Full Text] [Related]
19. Yellow nail syndrome: treatment with octreotide.
Hillerdal G
Clin Respir J; 2007 Dec; 1(2):120-1. PubMed ID: 20298292
[TBL] [Abstract][Full Text] [Related]
20. [Upper respiratory tract manifestations in yellow nail syndrome].
Primov-Fever A; Kronenberg J; Talmi YP
Harefuah; 2002 Oct; 141(10):871-2, 931. PubMed ID: 12420589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
